I think everybody here is interested. When we did the pharmaceutical study, the single issue that seemed to come up most was diabetes. It came up all the time from many witnesses. It is obviously a big issue.
I think we all agree, and maybe the words don't cover everything, but if we get into the committee, I think we'll cover everything.
I'm going to move to the motion now.
Mr. Davies, did you want to speak?